ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,660Medicare Part D Prescriptions Filled, Including Refills

Rank: 198 out of 625

$513K Total Retail Price of All Prescriptions

Rank: 176 out of 625

371 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 371 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 371 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 6,063 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
SIMVASTATIN 343 280 1 2
LEVOTHYROXINE SODIUM 313 262 2 3
AMLODIPINE BESYLATE 254 239 3 1
OMEPRAZOLE 248 180 4 6
HYDROCODONE-ACETAMINOPHEN 203 90 S3 5 4
LISINOPRIL 185 155 6 5
ZOLPIDEM TARTRATE 179 124 7 13
METOPROLOL SUCCINATE 171 148 8 15
FUROSEMIDE 133 93 9 7
ATENOLOL 123 100 10 22
ATORVASTATIN CALCIUM 113 106 11 9
WARFARIN SODIUM 112 99 12 20
NEXIUM 111 90 13 21
CYMBALTA 103 71 14 46
METOPROLOL TARTRATE 93 83 15 11
HYDROCHLOROTHIAZIDE 92 89 16 12
MELOXICAM 84 71 17 31
POTASSIUM CHLORIDE 83 80 18 19
DONEPEZIL HCL 77 77 19 33
METFORMIN HCL 74 56 20 10
CITALOPRAM HBR 71 58 21 24
PANTOPRAZOLE SODIUM 69 59 22 44
PRAVASTATIN SODIUM 69 65 22 8
DIOVAN 68 65 24 28
CLOPIDOGREL 67 60 25 30
LOSARTAN POTASSIUM 65 65 26 18
NAMENDA 63 63 27 45
CRESTOR 58 51 28 17
TRAMADOL HCL 58 54 28 16
OXYCODONE-ACETAMINOPHEN 57 30 S2 30 95
PAROXETINE HCL 56 34 31 76
CELEBREX 55 53 32 72
ALENDRONATE SODIUM 55 54 32 34
OXYCODONE HCL-ACETAMINOPHEN 54 52 S2 34 87
TRIAMTERENE-HCTZ 53 53 35 53
PLAVIX 52 43 36 43
KLOR-CON M20 51 48 37 47
LEXAPRO 50 49 38 196
HYDRALAZINE HCL 50 50 38 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.